Background: Aluminium-containing phosphate binders have long been used for treatment of hyperphosphatemia in dialysis patients. Their safety became controversial in the early 1980's after reports ...

With more-advanced renal failure, phosphate binders become necessary to maintain phosphate balance and to prevent hyperphosphatemia. Because of toxicity, aluminum-containing phosphate binders are ...

Hyperphosphatemia is linked to increased mortality risk. Dialysis patients often face a high daily pill burden, with phosphate binders making up about 50% of the total. Nonadherence to phosphate ...

The review highlights the challenges faced by patients regarding current phosphate binders, particularly focusing on issues like high pill burdens and gastrointestinal side effects, which ...

AJ Rice, UBS: Asked about patient care cost growth outside of phosphate binders. Ackerman noted a 3.75% anticipated growth in historical costs, primarily from labor and other expenses. Pito ...

Starting Jan. 1, Medicare rolled payments for seven different oral-only phosphate binders into its End Stage Renal Disease Prospective Payment System, a bundle in place since 2011. Most affected ...

Dialysis patients often face a high daily pill burden, with phosphate binders making up about 50% of the total. Nonadherence to phosphate binders is a significant challenge contributing to ...

(MENAFN- GlobeNewsWire - Nasdaq) Large pill size, high pill burden and palatability were identified as key barriers for phosphate binder adherence LOS ALTOS, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE ...

focusing on the limitations of current phosphate binders and their effect on patients' quality of life. The publication underscores key findings from patient surveys and medical literature, ...